Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

BACKGROUND: Individuals with diabetes often have high levels of atherogenic lipoproteins and cholesterol reflected by elevated low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B (ApoB), and LDL particle number (LDL-PN). The presence of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Ray, Kausik K., Del Prato, Stefano, Müller-Wieland, Dirk, Cariou, Bertrand, Colhoun, Helen M., Tinahones, Francisco J., Domenger, Catherine, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Bujas-Bobanovic, Maja, Leiter, Lawrence A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842201/
https://ncbi.nlm.nih.gov/pubmed/31706300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0951-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars